Rei Tsang Shiao

Array ( [id] => 7217988 [patent_doc_number] => 20050054819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors' [patent_app_type] => utility [patent_app_number] => 10/501636 [patent_app_country] => US [patent_app_date] => 2003-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36574 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054819.pdf [firstpage_image] =>[orig_patent_app_number] => 10501636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822208 [patent_doc_number] => 20030220369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function' [patent_app_type] => new [patent_app_number] => 10/332941 [patent_app_country] => US [patent_app_date] => 2003-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13205 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220369.pdf [firstpage_image] =>[orig_patent_app_number] => 10332941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 823832 [patent_doc_number] => 07405304 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-29 [patent_title] => 'Methods for the preparation of alkyl diaryl borinates and complexed diarylboronic acids' [patent_app_type] => utility [patent_app_number] => 10/501755 [patent_app_country] => US [patent_app_date] => 2003-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6696 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/405/07405304.pdf [firstpage_image] =>[orig_patent_app_number] => 10501755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740752 [patent_doc_number] => 20030158121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Novel $G(y)crystalline form of perindopril tert- butylamine salt, preparation method, and pharmaceutical compositions containing same' [patent_app_type] => new [patent_app_number] => 10/312903 [patent_app_country] => US [patent_app_date] => 2002-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1634 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158121.pdf [firstpage_image] =>[orig_patent_app_number] => 10312903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730706 [patent_doc_number] => 20030186896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Crystalline form of perindopril tert-butylamine salt' [patent_app_type] => new [patent_app_number] => 10/312961 [patent_app_country] => US [patent_app_date] => 2002-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1401 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186896.pdf [firstpage_image] =>[orig_patent_app_number] => 10312961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 830221 [patent_doc_number] => 07399775 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-15 [patent_title] => 'β-amyloid protein production/secretion inhibitor' [patent_app_type] => utility [patent_app_number] => 10/500156 [patent_app_country] => US [patent_app_date] => 2002-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 144148 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/399/07399775.pdf [firstpage_image] =>[orig_patent_app_number] => 10500156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020404 [patent_doc_number] => 20050222423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Carboxylic acid derivative' [patent_app_type] => utility [patent_app_number] => 10/500135 [patent_app_country] => US [patent_app_date] => 2002-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11965 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222423.pdf [firstpage_image] =>[orig_patent_app_number] => 10500135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829122 [patent_doc_number] => 20060063769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Preventives/remedies for urinary disturbance' [patent_app_type] => utility [patent_app_number] => 10/500217 [patent_app_country] => US [patent_app_date] => 2002-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 148208 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063769.pdf [firstpage_image] =>[orig_patent_app_number] => 10500217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1002484 [patent_doc_number] => 06908939 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-21 [patent_title] => 'Biaromatic ligand activators of PPARγ receptors' [patent_app_type] => utility [patent_app_number] => 10/326054 [patent_app_country] => US [patent_app_date] => 2002-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15674 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/908/06908939.pdf [firstpage_image] =>[orig_patent_app_number] => 10326054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7473956 [patent_doc_number] => 20040121989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Renal-selective biphenylalkyl 1H-substituted-1,2,4-triazole angiotensin II antagonists for treatment of hypertension' [patent_app_type] => new [patent_app_number] => 10/326942 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 70025 [patent_no_of_claims] => 108 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121989.pdf [firstpage_image] =>[orig_patent_app_number] => 10326942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725603 [patent_doc_number] => 20030207915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Compounds that modulate PPAR activity and methods of preparation' [patent_app_type] => new [patent_app_number] => 10/324266 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20912 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207915.pdf [firstpage_image] =>[orig_patent_app_number] => 10324266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7412186 [patent_doc_number] => 20040106670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Crystalline form' [patent_app_type] => new [patent_app_number] => 10/323241 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2334 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106670.pdf [firstpage_image] =>[orig_patent_app_number] => 10323241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 948964 [patent_doc_number] => 06963000 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-08 [patent_title] => 'Benzothiazole derivatives with activity as adenosine receptor ligands' [patent_app_type] => utility [patent_app_number] => 10/322272 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41235 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/963/06963000.pdf [firstpage_image] =>[orig_patent_app_number] => 10322272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 733437 [patent_doc_number] => 07038025 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-02 [patent_title] => 'Metal complexes of heterocyclic aromatic compounds' [patent_app_type] => utility [patent_app_number] => 10/468982 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 26 [patent_no_of_words] => 6423 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/038/07038025.pdf [firstpage_image] =>[orig_patent_app_number] => 10468982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6684007 [patent_doc_number] => 20030119871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Amidine derivatives as selective antagonists of ndma receptors' [patent_app_type] => new [patent_app_number] => 10/311273 [patent_app_country] => US [patent_app_date] => 2002-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9534 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119871.pdf [firstpage_image] =>[orig_patent_app_number] => 10311273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122893 [patent_doc_number] => 20050014722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Process for preparing n-acylated lysophosphatidylcholine and pharmaceutical composition for treatment of metabolic bone disease comprising said compounds' [patent_app_type] => utility [patent_app_number] => 10/497893 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9697 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014722.pdf [firstpage_image] =>[orig_patent_app_number] => 10497893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 779405 [patent_doc_number] => 06995273 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-07 [patent_title] => '1H-pyrazolo[1,5-b]-1,2,4-triazole compound, coupler and silver halide color photographic light-sensitive material' [patent_app_type] => utility [patent_app_number] => 10/316021 [patent_app_country] => US [patent_app_date] => 2002-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17858 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/995/06995273.pdf [firstpage_image] =>[orig_patent_app_number] => 10316021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6666370 [patent_doc_number] => 20030111353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Gold complex' [patent_app_type] => new [patent_app_number] => 10/315016 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2311 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20030111353.pdf [firstpage_image] =>[orig_patent_app_number] => 10315016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7314866 [patent_doc_number] => 20040034172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Flame-retardant acrylophosphate derivatives' [patent_app_type] => new [patent_app_number] => 10/315092 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2431 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20040034172.pdf [firstpage_image] =>[orig_patent_app_number] => 10315092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 606629 [patent_doc_number] => 07153994 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-26 [patent_title] => 'Manufacture of trimethylhydroquinone diacylates' [patent_app_type] => utility [patent_app_number] => 10/498626 [patent_app_country] => US [patent_app_date] => 2002-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2928 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/153/07153994.pdf [firstpage_image] =>[orig_patent_app_number] => 10498626 [rel_patent_id] =>[rel_patent_doc_number] =>)